News

Jensen Huang's Perspective on Nvidia Stock: A Humble Approach

Jensen Huang's Perspective on Nvidia Stock: A Humble Approach

Jensen Huang's Perspective on Nvidia Stock Performance

NVIDIA Corporation (NASDAQ: NVDA) has experienced remarkable growth in 2024, significantly increasing the wealth of its CEO and co-founder, Jensen Huang. Interestingly, Huang has indicated that he sometimes does not monitor Nvidia's stock price on a daily basis. This absence of a daily check might surprise many, given the soaring value of the company.

The CEO's Daily Routine

When asked about his stock price habits during an appearance on CNBC's "Squawk Box," Huang responded casually, admitting, "Not every day; sometimes I'll look at the end of the day." This approach shows a refreshing detachment from day-to-day market fluctuations, which often preoccupy other CEOs.

Does Stock Performance Affect Huang's Mood?

During the interview, Huang was also queried whether the daily stock price impacts his emotional well-being. With a decisive "No," he conveyed that his sense of achievement is not tied to stock performance. This mindset reflects a focus on long-term vision and operational success rather than short-term valuation.

Nvidia's Impressive Market Achievements

Despite Huang's personal indifference towards daily stock price movements, Nvidia has become a behemoth in the tech industry. The company made headlines in May 2023, when it achieved a $1 trillion market capitalization, joining an elite group of corporations. Fast forward to the present, Nvidia has doubled that figure to $2 trillion in less than nine months and recently surpassed the $3 trillion mark within just 96 days, signifying its unprecedented growth trajectory.

Surpassing Tech Giants

Earlier this year, Nvidia peaked as the world's most valuable public company, briefly eclipsing renowned giants like Apple and Microsoft. Currently, it stands strong with a market cap of approximately $3.308 trillion, trailing just behind Apple's recent valuation of $3.466 trillion.

Huang's Journey: From Humble Beginnings

Huang emphasizes that Nvidia's success has been a long time coming, stating, "32 years" when reflecting on the company’s journey. Co-founded alongside Chris Malachowsky and Curtis Priem in an unassuming Denny's restaurant, Nvidia's origins are rooted in humble beginnings that have come a long way to reach its current status.

Current Wealth and Influence

Today, Jensen Huang finds himself as the 11th richest individual globally, with a staggering net worth of $118 billion, according to Bloomberg. The remarkable rise in Nvidia's stock has contributed an astounding $73.8 billion to Huang's wealth just in 2024, marking a significant gain amidst a highly competitive arena of billionaires.

Financial Performance Update

Nvidia stock is currently trading at $134.85. Over the past year, it has shown impressive performance, with a 52-week trading range between $39.23 and $140.76, reflecting a notable increase of 180% year-to-date in 2024.

Frequently Asked Questions

1. Does Jensen Huang monitor Nvidia's stock daily?

No, he sometimes checks the stock price at the end of the day instead of daily.

2. How does Huang feel about Nvidia's market valuation?

He indicates that it does not impact his emotional state; he remains focused on the company's long-term goals.

3. What milestone did Nvidia achieve in May 2023?

Nvidia reached a market capitalization of $1 trillion in May 2023, showcasing its rapid growth.

4. What is Huang's current net worth?

Jensen Huang is currently worth $118 billion as reported.

5. What significant growth did Nvidia see in 2024?

The stock has risen by 180% year-to-date, contributing substantially to Huang's wealth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 19

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 24

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 30

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 18

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 25

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Alterity Therapeutics Showcases Innovation at Healthcare Event

Updated Category News Views 142

Alterity Therapeutics to Present at a Virtual Healthcare Conference Alterity Therapeutics, a biotechnology firm dedicated to developing treatments for neurodegenerative diseases, has recently announced its participation in an upcoming healthcare virtual conference. The event will shine a spotlight on influential healthcare companies and their innovative approaches to...

Continue Reading
Important Update for Toronto-Dominion Bank Investors on Lawsuit

Updated Category News Views 58

Update for Investors in Toronto-Dominion Bank Kahn Swick & Foti, LLC, led by the experienced former Louisiana Attorney General Charles C. Foti, Jr., is reminding investors that significant changes are arriving for shareholders of Toronto-Dominion Bank (NYSE: TD). As the legal landscape evolves, those who experienced losses may want to take immediate action regarding their...

Continue Reading
GCC's Quarterly Performance Analysis: Key Insights Revealed

Updated Category News Views 221

GCC Reports Significant First Quarter Financials GCC, S.A.B. de C.V. (BMV: GCC*), recognized as a premier supplier and producer of cement, concrete, and aggregates, has shared its financial results for the first quarter. Despite facing various challenges, GCC's performance metrics reveal a resilience that is noteworthy. Q1 2025 Highlights In the first quarter of 2025, GCC...

Continue Reading
Indonesia's IDX Composite Index Declines Amid Market Pressures

Updated Category News Views 116

Overview of Recent Market Movements in Indonesia Indonesia's stock market experienced a downturn at the close of trading, influenced by various sectors showing significant losses. The IDX Composite Index reflected a decrease of 0.98%, marking a notable dip to a one-month low. This downturn is primarily attributed to declines in several key sectors, including...

Continue Reading
Blink Charging Achieves Advanced Certification for EV Chargers

Updated Category News Views 130

Blink Charging Receives Prestigious OCPP 2.0.1 Certification Blink stands out as one of just five EV charging companies in the U.S. to earn this coveted certification. Bowie, Md. – Blink Charging Co. (NASDAQ: BLNK), a prominent name in electric vehicle (EV) charging equipment and services, has proudly announced that its Series 7, 8, and 9 charger models have...

Continue Reading